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Abstract
Objective: Chronic low-grade inflammation and adipokines dysregulation are linked to mechanisms underscoring the
pathogenesis of obesity-related metabolic disorders. Little is known about roles of these cytokines on the association
between snoring and metabolic syndrome (MetS). We aimed to investigate whether a cluster of cytokines are related to
snoring frequency and its association with MetS in apparently healthy Chinese.
Methods: Current analyses used a population-based sample including 1059 Shanghai residents aged 35–54 years. Self-
reported snoring frequency was classified as never, occasionally and regularly. Fasting plasma glucose, lipid profile, insulin,
C-reactive protein, interleukin-6, interleukin-18, lipopolysaccharide binding protein, high-molecular-weight adiponectin and
leptin were measured. MetS was defined by the updated National Cholesterol Education Program Adult Treatment Panel III
criteria for Asian-Americans.
Results: Overweight/obese subjects had significantly higher prevalence of regular snorers than their normal-weight
counterparts (34.8% vs. 11.5%, P,0.001). Regular snoring was associated with unfavorable profile of inflammatory markers
and adipokines. However, those associations were abolished after adjustment for body mass index (BMI) or waist
circumference. The MetS risk (multivariate-adjusted odds ratio 5.41, 95% confidence interval 3.72–7.88) was substantially
higher in regular snorers compared with non-snorers. Controlling for BMI remarkably attenuated the association (2.03, 1.26–
3.26), while adjusting for inflammatory markers and adipokines showed little effects.
Conclusion: Frequent snoring was associated with an elevated MetS risk independent of lifestyle factors, adiposity,
inflammatory markers and adipokines in apparently healthy Chinese. Whether snoring pattern is an economic and no-
invasive indicator for screening high-risk persons needs to be addressed prospectively.
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Introduction
Habitual snoring, a manifestation of sleep-disordered breathing
(SDB), has been suggested to be associated with various cardio-
metabolic disorders, such as insulin resistance, hypertension,
metabolic syndrome (MetS), type 2 diabetes, and cardiovascular
diseases (CVD) by several epidemiological studies [1–7]. Although
specific mechanism(s) has yet to be established, compelling
evidence showed that chronic low-grade inflammation and
adipokines dysregulation could mediate unfavorable effects of
obesity on the pathogenesis of metabolic diseases. Previously,
circulating adiponectin was reported to be associated with frequent
snoring among women with type 2 diabetes, which postulated a
potential mechanism explaining the relationship between snoring
and cardio-metabolic disorders [8]. However, the associations of
SDB/snoring with inflammatory and adipose cytokines like C-
reactive protein (CRP), leptin and adiponectin were often
inconsistent when taking general or central obesity into account
[8–14].
Compared with Caucasians, Asian populations, including
Chinese, tend to have higher abdominal and visceral adiposity
at a given level of body mass index (BMI) [15], namely
‘metabolically obese’ phenomenon [16]. They are also thought
to have higher susceptibility for metabolic diseases like type 2
diabetes than Caucasians even with lower BMI [17]. However, it is
unknown whether these unique obesity phenotypes have any
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Although excess fat mass, high levels of CRP, interleukin-18 (IL-
18), leptin and low adiponectin concentration were associated with
higher MetS risk in our and other populations [18–22], it remains
to be elucidated whether the association between snoring
frequency and MetS is independent or mediated through
traditional risk factors, and/or unfavorable profile of inflammatory
and adipose cytokines.
In light of these controversies and gaps in available literatures,
we aimed to systematically investigate: 1) whether snoring
frequency was related with various inflammatory markers (CRP,
IL-6, IL-18 and lipopolysaccharide binding protein [LBP]) and
adipokines (high-molecular-weight [HMW]-adiponectin and lep-
tin); 2) whether snoring frequency was associated with MetS and to
what extent that the association could be explained by lifestyle
factors, adiposity status, inflammatory markers and adipokines in
apparently healthy Chinese men and women.
Methods
Ethics Statement
The study was approved by the Institutional Review Board of
the Institute for Nutritional Sciences and written informed consent
was obtained from each participants.
Study population
This study included a population-based case-control sample of
non-institutionalized residents aged 35 to 54 years in Shanghai,
China. Two urban districts (Luwan and Zhabei) were chosen to
represent people from high to low socioeconomic status in urban
Shanghai. Participants were enrolled through their response to
an advertisement. Five hundred pairs of age and sex matched
cases (overweight/obesity, BMI $24.0 kg/m
2)a n dc o n t r o l s
(normal-weight, 18#BMI,24.0 kg/m
2)w e r ep l a n n e dt ob e
recruited. Eligible candidates were adult residents who had lived
in Shanghai for at least 10 years. Exclusion criteria included 1)
diarrhea for 3 consecutive days within previous 3 months; 2)
heavy alcohol consumption ($40 g/day ethanol for men and
$20 g/day for women); 3) physician-diagnosed diabetes (or on
oral anti-diabetic agents or insulin), cancer, coronary heart
disease, myocardial infarction, stroke, severe kidney or liver
diseases; 4) infectious diseases including tuberculosis, AIDS and
hepatitis; 5) severe psychological disorders or physical disabili-
ties; 6) antibiotics used for 3 consecutive days within previous 3
months; 7) gastrointestinal surgery within 1 year; or 8) women
during pregnancy or lactation. A total of 1059 (559 overweight/
obese and 500 normal-weight) subjects were successfully
recruited. Information on demographic variables, health status
and behaviors was obtained using a standardized questionnaire
[23]. Following a home interview of the questionnaires, all
participants were asked to fast overnight before having a physical
examination. Body weight, height, waist circumference and
blood pressure were measured using a standardized protocol
[23].
Individuals without data of snoring frequency (56, 5.3%) were
excluded and the final analyses included 1003 participants (392
men and 611 women), in which 534 were normal-weight and 469
were overweight/obese subjects.
Laboratory methods
Fasting peripheral venous EDTA blood samples were collected
and centrifuged at 4uC, 3000 rpm for 15 min. After being frozen,
the samples were shipped in dry ice to the Institute for Nutritional
Sciences and stored at 280uC until analyses. The measurements
of total cholesterol, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, triglycerides, glucose,
glycohaemoglobin (HbA1c), insulin, CRP, IL-6, IL-18, LBP,
HMW-adiponectin and leptin were described previously [20,23].
The insulin resistance index (homeostatic model assessment of
insulin resistance [HOMA-IR]) was calculated according to
updated homeostasis model assessment methods (http://www.
dtu.ox.ac.uk/).
Assessment of sleep, snoring and related factors
Snoring frequency was obtained from the responses to the
question ‘‘Do you snore during the last month?’’ with 3 levels
(regularly, occasionally or never). Subjective sleep quality during
the last month was recorded in 3 categories (very well, fair or
poor). Sleep duration was measured by self-reported average total
hours of daily sleep during the previous month, including both
night and nap hours of sleep and was categorized as ,7.0, 7.0 to
8.9 and $9 hours per day, respectively.
Current smoking status was defined as never, former and
current smoker. Current alcohol drinking was defined as a binary
variable (yes, no). Physical activity data was collected by
International Physical Activity Questionnaire (short last 7-day
format, http://www.ipaq.ki.se/scoring.pdf), and level for each
individual was calculated as a sum of metabolic equivalent (MET)-
minute/week score and then classified as a binary variable
determined by below or above the sex-specific total MET median.
Educational attainment was categorized into 3 groups (0 to 9, 10
to 12 and $13 years of education). Family history of chronic
diseases was positive if a parent or sibling was reported to have
coronary heart disease, stroke or type 2 diabetes. Marital status
was classified as with or without spouse/partner. Total household
annual income was categorized into 3 levels (,20000, 20000 to
79999 and $80000 RMB).
Self-rated health status was initially recorded in 5 levels (very
good, good, fair, poor and very poor) and then combined into two
categories: good (very good and good) and poor (fair, poor and
very poor). Center for Epidemiologic Studies Short Depression
Scale (10-item CES-D scale) was used to measure the presence of
clinically relevant depressive symptoms with the cut-off point of 10
[24].
Definition of metabolic syndrome
MetS was defined according to the updated National
Cholesterol Education Program Adult Treatment Panel III
criteria for Asian-Americans [25], which includes at least 3 of
the following components: 1) waist circumferences $90 cm in
men or $80 cm in women; 2) triglycerides $1.7 mmol/L; 3)
HDL cholesterol ,1.03 mmol/L in men or ,1.30 mmol/L in
women; 4) blood pressure $130/85 mmHg, or current use of
anti-hypertensive medications; and 5) fasting plasma glucose
$5.6 mmol/L.
Statistical analyses
Analysis of covariance for continuous variables and logistic
regression models for categorical variables were applied for the
characteristics comparison across snoring frequency (never,
occasionally and regularly). Linear trends among cardiometa-
bolic biomarkers across snoring frequency were analyzed by
simple and multiple linear regression models. Log-transforma-
tions were performed for triglycerides, insulin, HOMA-IR, CRP,
IL-6, IL-18, LBP, HMW-adiponectin and leptin to approximate
normality. Multivariate logistic regression models were applied
to estimate the odds ratio (OR) for MetS and its components.
Adjusted potential confounders included age, sex, lifestyle
Snoring and Metabolic Syndrome
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marital status, annual income, self-rated health status, depressive
symptoms, sleep quality, sleep duration and BMI. Inflammatory
factors (CRP, IL-6, IL-18 and LBP) and adipokines (HMW-
adiponectin and leptin) were further included to test whether the
association was explained by these biomarkers. The ORs for
MetS were also calculated according to joint classification of
snoring frequency and sex, age groups (35–44, and 45–54 yrs
old), obesity status (normal weight, and overweight/obesity), or
cytokine index. The inflammatory index and adipokine index
were computed as follows: (CRP z score + IL-6 z score + LBP z
score + IL-18 z score)/4 and (adiponectin z score * (21) + leptin
z score)/2. Data management and statistical analyses were
performed using Stata 9.2 (Stata, College Station, TX).




The prevalence of regular snoring was significantly higher in
overweight/obese participants than their normal-weight counter-
parts after controlling for age and sex (34.8% vs. 11.5%, P,0.001).
Compared with none-snorers, snorers were more likely to be older,
male, alcohol drinker, and they also have higher prevalence of
MetS (all P,0.05; Table 1) and lower percentage of self-rated
good health status (P = 0.006). Meanwhile, regular snorers also
exhibited higher levels of BMI, waist circumference and blood
pressure (all P,0.001).
Cardiometabolic biomarkers across snoring frequency
In simple linear regression models, more frequent snoring was
significantly associated with higher values of insulin, HOMA-IR,
Table 1. Characteristics of participants across snoring frequency (n=1003).
Never Occasionally Regularly P value
N 396 367 240 –
Age (yrs)
a 45.4 (5.4) 46.5 (5.3) 46.1 (5.6) 0.020
Men (n, %)
a 109 (27.5) 149 (40.6) 134 (55.8) ,0.001
Low physical activity (n, %) 192 (48.5) 188 (51.2) 121 (50.4) 0.732
Education level (n, %) 0.792
0,9 yrs 98 (24.8) 99 (27.0) 75 (31.3)
10,12 yrs 222 (56.1) 199 (54.2) 111 (46.3)
.12 yrs 76 (19.2) 69 (18.8) 54 (22.5)
Current smoker (yes, n, %) 75 (18.9) 95 (25.9) 99 (41.3) 0.127
Alcohol drinker (yes, n, %) 109 (27.5) 133 (36.2) 123 (51.3) 0.005
Family history of chronic diseases (n, %) 152 (38.4) 141 (38.4) 110 (45.8) 0.076
Metabolic syndrome (n, %) 108 (27.3) 163 (44.4) 159 (66.3) ,0.001
Current marriage (n, %) 360 (90.9) 346 (94.3) 222 (92.5) 0.145
Annual income (yuan) (n=901) 0.858
,20000 84 (22.7) 69 (21.0) 43 (21.3)
20000–79999 236 (63.8) 221 (67.2) 138 (68.3)
$80000 50 (13.5) 39 (11.9) 21 (10.4)
Self-rated good health status (n, %) 201 (50.8) 169 (46.1) 98 (40.8) 0.006
Depressive symptoms (n, %) 16 (4.0) 23 (6.3) 15 (6.3) 0.180
Sleeping pills intake (n, %) 4 (1.0) 0 (0.0) 1 (0.4) 0.523
Sleep quality (n, %) (n=998) 0.127
Well 190 (48.5) 179 (48.9) 141 (58.8)
Common 172 (43.9) 165 (45.1) 75 (31.3)
Poor 30 (7.7) 22 (6.0) 24 (10.0)
Sleep duration (n, %) 0.239
,7.0 hrs/day 80 (20.2) 63 (17.2) 56 (23.3)
7.0–8.9 hrs/day 276 (69.7) 261 (71.1) 147 (61.3)
$9.0 hrs/day 40 (10.1) 43 (11.7) 37 (15.4)
BMI (kg/m
2) 23.3 (3.7) 24.7 (3.8) 27.0 (4.2) ,0.001
Waist circumference (cm) 80.5 (9.9) 85.5 (10.2) 92.5 (11.5) ,0.001
Systolic Blood Pressure (mmHg) 120.9 (16.8) 125.3 (17.5) 132.0 (17.8) ,0.001
Diastolic Blood Pressure (mmHg) 76.4 (11.1) 79.9 (10.9) 85.1 (12.0) ,0.001
P value was calculated after adjustment for age and sex. Data are arithmetic mean (SD).
aData not adjusted for itself.
Percentages may not sum to 100 because of rounding.
Abbreviations: BMI = body mass index.
doi:10.1371/journal.pone.0027515.t001
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and LBP), and lower concentrations of HDL and HMW-
adiponectin (all P,0.05; Table S1). Controlling for age, sex
and multivariate factors did not attenuate the results. However,
further adjustment for BMI or waist circumference abolished the
significant associations for most cardiometabolic biomarkers,
particularly adiponkines and inflammatory markers.
Associations of snoring with metabolic syndrome
The risk for MetS increased progressively across snoring
frequency (P,0.001 for trend; Table 2) and regular snorers had
an OR of 5.41 (95% confidence interval [CI], 3.72–7.88)
compared with none-snorers, after adjusting various covariates
(Model 1). Similar trends were also observed for the MetS
components except for hyperglycemia. The ORs of MetS and its
components (central obesity and hypertriglyceridemia) were
attenuated but remained significant by additionally controlling
for BMI (Model 2), and the OR for MetS was 2.03 (95% CI,
1.26–3.26) in regular snorers compared with none-snorers; while
strength of the associations were not substantially altered by
further adjusting for inflammatory markers and adipokines (OR
for MetS, 1.95; 95% CI, 1.18–3.20; Model 3). Similar results
were obtained after excluding 140 subjects with type 2 diabetes
(Table 2).
Joint classification analyses were conducted to examine whether
sex, age, obesity, inflammatory index and adipokine index could
modify the associations between frequent snoring and the MetS
risk (Figure 1). No significant interactions were observed (P.0.05
for all interaction tests) and the association persisted in all strata.
Discussion
Our data showed that the associations of regular snoring with
unfavorable levels of inflammatory markers and adipokines were
mainly explained by obese status. However, regular snoring was
Table 2. Odds ratios and 95% confidence interval for metabolic syndrome according to snoring frequency (n=1003).
Never Occasionally Regularly P for trend
Metabolic syndrome 108/396 163/367 159/240
Model 1 1 2.15 (1.57–2.94) 5.41 (3.72–7.88) ,0.001
Model 2 1 1.46 (0.98–2.18) 2.03 (1.26–3.26) 0.003
Model 3 1 1.45 (0.96–2.19) 1.95 (1.18–3.20) 0.007
Metabolic syndrome
a 78/347 124/316 122/200
Model 1 1 2.30 (1.61–3.27) 5.67 (3.74–8.58) ,0.001
Model 2 1 1.59 (1.02–2.47) 2.16 (1.29–3.64) 0.003
Model 3 1 1.47 (0.94–2.32) 1.98 (1.15–3.42) 0.012
Central obesity 145/396 202/367 180/240
Model 1 1 2.44 (1.79–3.31) 6.98 (4.68–10.39) ,0.001
Model 2 1 1.97 (1.10–3.51) 2.63 (1.28–5.39) 0.005
Model 3 1 2.01 (1.10–3.65) 2.59 (1.23–5.48) 0.007
Elevated blood pressure 123/396 158/367 142/240
Model 1 1 1.48 (1.09–2.02) 2.88 (2.00–4.14) ,0.001
Model 2 1 1.08 (0.77–1.51) 1.33 (0.88–2.00) 0.194
Model 3 1 1.06 (0.75–1.50) 1.26 (0.83–1.93) 0.300
Hypertriglyceridemia 84/396 123/367 116/240
Model 1 1 1.76 (1.25–2.48) 3.09 (2.11–4.51) ,0.001
Model 2 1 1.38 (0.96–1.98) 1.61 (1.06–2.45) 0.023
Model 3 1 1.36 (0.94–1.97) 1.55 (1.01–2.38) 0.042
Low HDL cholesterol 121/396 138/367 107/240
Model 1 1 1.51 (1.10–2.07) 2.12 (1.47–3.05) ,0.001
Model 2 1 1.23 (0.89–1.71) 1.24 (0.83–1.84) 0.248
Model 3 1 1.18 (0.84–1.66) 1.26 (0.83–1.91) 0.262
Hyperglycemia 240/396 235/367 161/240
Model 1 1 1.15 (0.85–1.56) 1.32 (0.91–1.90) 0.133
Model 2 1 1.01 (0.74–1.38) 0.94 (0.63–1.40) 0.803
Model 3 1 1.03 (0.75–1.41) 0.93 (0.62–1.38) 0.770
aExcluding 140 participants who met the criteria for type 2 diabetes during the physical examinations;
Model 1: adjusted for age, sex, smoking, alcohol drinking, physical activity, education, family history of chronic diseases, marital status, annual income, self-rated health
status, depressive symptoms, sleep quality and duration;
Model 2: model 1 plus BMI;
Model 3: model 2 plus inflammatory markers (CRP, LBP, IL-6 and IL-18) and adipokines (HMW-adiponectin and leptin).
Abbreviations: BMI = body mass index; CRP = C-reactive protein; HDL = high-density lipoprotein; HMW-adiponectin = high-molecular-weight adiponectin; IL =
Interleukin; LBP = Lipopolysaccharide-binding protein.
doi:10.1371/journal.pone.0027515.t002
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risk factors like lifestyle factors, adiposity, inflammatory markers
and adipokines were extensively controlled in apparently healthy
Chinese men and women. The findings of our study provide
further insights into potential mechanism(s) involved in the
association between snoring status and metabolic disorders.
Figure 1 Odds ratio for metabolic syndrome according to joint classification of snoring status and sex (A), age (B), obesity status
(C), inflammatory index (D) and adipokine index (E). Modified metabolic syndrome was defined as having 2 or more components of metabolic
syndrome without central obesity. At oB : Adjusted for age (A), sex (B), smoking, alcohol drinking, physical activity, education, family history of
chronic diseases, marriage status, annual income, self-rated health status, depressive symptoms, sleep quality and duration, and BMI. C: Adjusted for
age, sex, smoking, alcohol drinking, physical activity, education, family history of chronic diseases, marriage status, annual income, self-rated health
status, depressive symptoms, sleep quality and duration. Dt oE : Adjusted for covariates in C and BMI. Abbreviations: BMI = body mass index.
doi:10.1371/journal.pone.0027515.g001
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frequency was found to be independently associated with
triglycerides, HDL and adiponectin in American diabetic women
[8], we also observed that frequent snoring was significantly
associated with an adverse profile of cardiometabolic biomarkers
including insulin, HOMA-IR, triglycerides, HDL, adipokines
(HMW-adiponectin, leptin) and inflammatory markers (CRP, IL-
6, IL-18 and LBP) in an apparently healthy Chinese population.
However, unlike that study, most of the associations, particularly
adiponkines and inflammatory markers in our study seem to be
explained by accumulated adipose status indicated by BMI or waist
circumference. Indeed, controversial results have been reported in
several studies when considering the influence of obesity on the
associations [8–14]. For instance, Ulukavak and coworkers [14]
observed that serum leptin was associated with apnea-hypopnea
index (AHI) independent of BMI in obese Turkish SDB patients;
whereas, Ip et al [26] indicated that body fat parameters rather than
AHI were predictors for leptin levels in German SDB patients. The
discrepancies among studies might be due to differences in ethnics,
study design and/or severity of obesity. Since adipokines and/or
proinflammatory cytokines are largely derived from adipose tissue
[27], it is also unclear that to what degree the ‘metabolically obese’
phenomenon and different profile of inflammatory markers in
Chinese population could influence the above associations
[16,17,19]. Certainly, more studies are deserved in this aspect.
In the present study, BMI is showed to be the most influential
factor involved in the associations of regular snoring with the MetS
and its features, indicated by controlling for BMI largely
attenuated the snoring-MetS association and even abolished
significant associations with elevated blood pressure and low
HDL cholesterol (Table 2). It appears that accumulating
adiposity in our population served as a critical mechanistic linking
between snoring and metabolic disorders. Supporting evidence
also came from some of cohort and intervention studies [28-30].
For example, based upon the data from the Wisconsin Sleep
Cohort Study, Peppard et al [28] discovered that weight gain was
associated with an increased development and severity of SDB;
whereas weight loss resulted in improvement of SDB. Notably, a
strong positive association between snoring frequency and central
obesity was persistent, even extensively adjusting for risk factors
such as BMI, lifestyle, depressive symptoms, sleeping quality and
duration, as well as multiple inflammatory cytokines and
adipokines. As active endocrine organ, adipose tissue secretes a
number of adipokines and promotes expression of inflammatory
markers which are proposed to mediate the adverse effects of
obesity on the development of metabolic diseases like type 2
diabetes and CVD [31,32]. In addition, fat deposition in the upper
airway lumen and muscle could reduce tracheal traction and lung
volume, resulting in and worsening the obstruction of upper
airway [33,34], which might provide potential mechanism(s)
between obesity and the pathogenesis of SDB/snoring. Taken
together, findings of our study further emphasized the dominant
role of obesity on the relationship between snoring and the risk of
MetS when potential confounders were extensively controlled.
Our study provided more supporting evidence that frequent
snoring was a strong and independent risk factor for MetS among
Chinese, regardless the fact that controlling for BMI remarkably
reduced the association (Table 2). The independent role of
snoring status was also suggested by the observations that no
interactions were detected between snoring with overweight/
obesity, inflammatory markers or adipokines in the joint
classification analyses (Figure 1A to 1C). Therefore, our findings
implicates that frequent snoring might attribute to metabolic
abnormalities via mechanism(s) beyond obesity and related
inflammation and adipokine dysregulation. Although specific
mechanism(s) is not fully understood, existing literatures suggested
that SDB induced hypoxia and hypercapnia might stimulate
sympathetic nervous activity [35] and generate more circulating
catecholamine and cortisol [36,37], which consequently increase
insulin resistance [38]. Furthermore, hypoxia is also believed as an
atherogenic factor which might increase the risk for future cardio-
metabolic disturbance [39]. Previously, habitual snoring was
reported to add prognostic value for type 2 diabetes and CVD
independent of obesity by some of prospective studies [4–6].
Meanwhile, the findings from our study also supported that
frequent snoring could provide additional information over
putative risk biomarkers such as inflammatory markers and
adipokines for MetS in apparently healthy Chinese. Collectively,
self-reported snoring might be useful as a low-cost and no-invasive
indicator in screening persons with higher cardio-metabolic risk,
especially in developing countries.
To the best of our knowledge, this is the first study to thoroughly
examine how obese status, multiple inflammatory markers and
adipokines are related to snoring frequency and its association with
MetS risk in the Chinese population. Our study has provided
further insights in understanding the mechanism(s) linking snoring
to cardio-metabolic disorders. Admittedly, there are limitations for
the study. Firstly, the information of snoring habits in our study
was obtained by questionnaires, a commonly used subjective
method, which might introduce recall bias. However, previous
studies have suggested the self-reported snoring to be a reliable
measurement in epidemiology studies [40,41]. Secondly, we did
not collect information about chronic obstructive pulmonary
disease (COPD), which may overlap with SDB in pathophysiology
and cardio-metabolic outcomes [42]. However, existing data
showed that the prevalence of COPD in urban Shanghai was
3.9% among subjects aged 40 years and older [43]. Moreover, the
COPD and obstructive sleep apnea syndrome only coexist in 1%
adult males [42]. Therefore, the snoring-MetS association was
unlikely to be altered substantially by taking COPD into account.
Moreover, the cross-sectional design could not allow establishing
the causal relation. The case-control nature of the sample might
limit our findings to be generalized in general populations.
Certainly, future studies are needed to confirm our results
prospectively in different populations.
Our study indicates that snoring frequency is significantly
associated with MetS, independent of obesity, inflammatory
factors and adipokines in apparently healthy Chinese. Whether
snoring status could serve as an economic and no-invasive
indicator for high risk individuals need to be determined
prospectively.
Supporting Information
Table S1 Crude and adjusted measure of cardiometa-
bolic biomarkers by snoring frequency (n=1003).
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